San Antonio, TX - SABCS 2011 San Antonio Breast Cancer Symposium: G von Minckwitz discusses S3-2. Neoadjuvant chemotherapy adapted by interim response improves overall survival of primary breast cancer patients - results of the GeparTrio trial during the General Session 3 at the 2011 San Antonio Breast Cancer Symposium here today, Thursday December 8, 2011. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 8, 2011 Photo by © SABCS/Todd Buchanan 2011 Technical Questions: email@example.com; Phone: 612-226-5154.
von Minckwitz G